scholarly journals Response to Letter Regarding Article, “Temporal Trends and Variation in Early Scheduled Follow-up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure

2016 ◽  
Vol 9 (6) ◽  
Author(s):  
Adam D. DeVore ◽  
Margueritte Cox ◽  
Zubin J. Eapen ◽  
Clyde W. Yancy ◽  
Deepak L. Bhatt ◽  
...  
2014 ◽  
Vol 63 (12) ◽  
pp. A745
Author(s):  
Adam DeVore ◽  
Margueritte Cox ◽  
Zubin Eapen ◽  
Clyde Yancy ◽  
Deepak Bhatt ◽  
...  

2016 ◽  
Vol 182 ◽  
pp. 9-20 ◽  
Author(s):  
Justin B. Echouffo-Tcheugui ◽  
Haolin Xu ◽  
Adam D. DeVore ◽  
Phillip J. Schulte ◽  
Javed Butler ◽  
...  

Author(s):  
Adam D. DeVore ◽  
Margueritte Cox ◽  
Zubin J. Eapen ◽  
Clyde W. Yancy ◽  
Deepak L. Bhatt ◽  
...  

BMJ Open ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. e043290
Author(s):  
Alicia Uijl ◽  
Ilonca Vaartjes ◽  
S Denaxas ◽  
Harry Hemingway ◽  
Anoop Shah ◽  
...  

ObjectiveWe examined temporal heart failure (HF) prescription patterns in a large representative sample of real-world patients in the UK, using electronic health records (EHR).MethodsFrom primary and secondary care EHR, we identified 85 732 patients with a HF diagnosis between 2002 and 2015. Almost 50% of patients with HF were women and the median age was 79.1 (IQR 70.2–85.7) years, with age at diagnosis increasing over time.ResultsWe found several trends in pharmacological HF management, including increased beta blocker prescriptions over time (29% in 2002–2005 and 54% in 2013–2015), which was not observed for mineralocorticoid receptor-antagonists (MR-antagonists) (18% in 2002–2005 and 18% in 2013–2015); higher prescription rates of loop diuretics in women and elderly patients together with lower prescription rates of angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers, beta blockers or MR-antagonists in these patients; little change in medication prescription rates occurred after 6 months of HF diagnosis and, finally, patients hospitalised for HF who had no recorded follow-up in primary care had considerably lower prescription rates compared with patients with a HF diagnosis in primary care with or without HF hospitalisation.ConclusionIn the general population, the use of MR-antagonists for HF remained low and did not change throughout 13 years of follow-up. For most patients, few changes were seen in pharmacological management of HF in the 6 months following diagnosis.


Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Indermohan Thethi ◽  
Kathie Thomas ◽  
Lynn Mallas-Serdynski

Background & Objectives: Heart failure (HF) is the leading cause of hospitalization among adults aged 65 or older. Despite advancements in medical therapy, HF readmission rates remain high. The average cost of each HF readmission is about $13,000. High rates of readmissions can lead to penalties of up to 3% of Medicare reimbursement, the reduction of costs, & the improvement of quality of care and patient outcomes, which makes reduction vital to hospitals. Having a follow up visit within 7 days of hospital discharge may help reduce HF readmissions. The objective of the abstract is to quantify the change in 7 day follow up visits and 30 day readmissions as part of the Get With The Guidelines (GWTG) HF quality improvement (QI) initiative. Methods: GWTG HF is an in-hospital quality initiative designed to improve care by promoting adherence to the latest scientific guidelines. A retrospective review was conducted of HF discharges from 19 hospitals using GWTG HF in Wisconsin and Michigan from 2011-2014. Readmission rates were determined from Centers for Medicare and Medicaid Services data. Results: 19 hospitals demonstrated improvement in the percentage of HF patients undergoing a follow-up visit within 7 days of hospital discharge when using GWTG HF as a QI program. As the percentage of HF patients receiving a follow-up visit within 7 days of hospital discharge increases, the number of readmissions decreases by 3% or 413 discharges over 4 years, which resulted in $5,369,000 cost savings. Conclusions: An in-hospital QI program, such as GWTG HF, improves the percentage of HF patients receiving a follow-up visit with 7 days of hospital discharge. Adherence to patient follow up visits for HF patients within 7 days of discharge leads to reduction in readmission rates. This translates into significant healthcare cost saving directly related to readmission in this patient category. Larger studies using a higher number of hospitals participating in quality programs is recommended.


Sign in / Sign up

Export Citation Format

Share Document